INSIGHTS ON CLINICAL TRIAL DESIGN
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Redefining Vaccine Trial Recruitment
Modern vaccine trials demand flexible, transparent recruitment workflows. Discover strategies to overcome enrollment delays and build representative, diverse study cohorts.
-
Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction
Centralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.
-
Decentralized Clinical Trials: FDA Guidance Analyzed
Explore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
4 Core Biomarker-Driven Study Designs In Oncology2/19/2026
Modern oncology demands smarter trial designs. Explore how enrichment, stratification, and basket models transform biomarker data into successful, regulatory-ready clinical programs.
-
A High-Touch, Patient-Centered Approach For Advancing Rare Disease Trials4/15/2025
On your journey to developing and executing a successful rare disease trial, it is critical to focus on patient experience and accessibility from the earliest stages of trial design.
-
Why Early Clinical Development Is Shifting Toward Decision-Enabling Study Designs6/9/2026
Early clinical research is shifting to decision-focused designs, using biomarkers, functional endpoints, and targeted populations to reduce uncertainty and enable clearer progression.
-
Precision Medicine: Targeted Cancer Therapies10/2/2025
Cancer research is entering a new precision-driven era, with targeted therapies focusing on the specific genetic or molecular mechanisms that fuel tumor growth.
-
The Impact Of Expert PK/PD Modeling In Psychedelic Research12/2/2025
Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
-
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.
-
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.
-
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
-
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.